The key event of the medical industry, with the State Corporation as the title partner, will be held in Gelendzhik from October 6 to 7.
Photo: Press service of Rostec State Corporation
The Rostec State Corporation will present over 30 models of the latest medical devices at the international forum "Bioprom: Industry and Technology for People." The exhibition will cover a wide range of fields—from surgery and intensive care to diagnostics, pharmacology, and prosthetics. One of the central exhibits will be the unique equipment in the field of transplantology, LIFE STREAM HEPAR, which improves the survival rate of donor organs.
The LIFE STREAM HEPAR hardware-software complex enables the rehabilitation of donor organs after tissue and vascular damage. The system is equipped with modern control and monitoring modules that automatically regulate and maintain optimal parameters. Since July 2025, the device has been undergoing testing at the S.P. Botkin Moscow Multidisciplinary Clinical Center. Preparations are underway for the serial production.
Additionally, Radioelectronic Technologies Concern will present the latest artificial ventilation device, Mobivent Arm-T, developed by the Ural Instrument Manufacturing Plant (a subsidiary of Kret). The equipment is designed for use in intensive care and operating rooms, as well as for patient transport in ambulances. The device is suitable for adults and children, equipped with modern ventilation modes, compact, and user-friendly. In June 2025, the device received registration certification from the Russian Ministry of Health and is now preparing for serial production.
Among other advanced Rostec devices to be showcased at Bioprom-2025 are the first serial domestic slide scanner, the OneCell 3.0, and the OneCell digital platform by Vansel (part of the Azimut management company). This AI-based hardware-software complex digitizes slides with biomaterial and identifies pathological tissues. The equipment helps doctors diagnose oncological diseases with maximum speed and accuracy. Capable of operating 24/7, the OneCell 3.0 can process nearly 300 samples simultaneously. The scanner has undergone trials at Sechenov University, the Petrovsky National Research Centre of Surgery, and other federal centers.
Two Rostec enterprises will present next-generation prosthetics: the Center for Innovations in Traumatology and Orthopedics (CITO) and the Metallist Production Association. Their exhibits will include the microprocessor-controlled "Kometa" knee module, implantable endosystems, and sports prosthetics that enable individuals with severe injuries to engage in active sports like running, cycling, and volleyball. These Rostec developments are already helping severely wounded participants of the Special Military Operation return to a full life activities.
The Natsimbio holding company of Rostec State Corporation will showcase original biological preparations for the treatment and prevention of infectious, neurological, and autoimmune diseases. Among them is Russia's first quadrivalent influenza vaccine, whose composition—in terms of the number of strains and active substance content—fully aligns with WHO recommendations, as well as immunoglobulins. It was developed using the holding's patented technology, which includes additional methods for protein purification and virus removal.
Exhibition visitors will also be introduced to bacteriophage preparations that selectively destroy pathogenic bacteria. Bacteriophages are considered as an effective tool for treating bacterial infections, including those resistant to antibiotics. All Natsimbio products are manufactured at the holding's facilities in a full cycle—from research and development to serial production.
"The development of domestic technologies in healthcare is a strategic priority for Rostec. Our goal is to reduce dependence on external supplies and create solutions that allow Russian medicine to reach a new level. Today, the Corporation's portfolio includes around 200 registered medical devices. These include innovative equipment, AI-based diagnostic systems, neonatal equipment, and high-tech prosthetics that help doctors save lives, improve the quality of treatment, and make modern technologies accessible to patients. In the coming years, we plan to increase our market presence fourfold, expand our product range, and establish serial production of the most in-demand equipment," — said Sergey Tsyb, State Secretary of Rostec State Corporation.
As part of the forum's business program, Rostec State Corporation will hold a plenary session titled "Transformation of the Medical Device Market: Global Trends, Local Solutions, and Development Perspectives." Medical equipment manufacturers, doctors, and experts will discuss issues of import substitution, generating demand for locally produced goods, integrating new technologies into the healthcare system, and developing skilled personnel for the medical industry.
Rostec will be the title partner of the International Forum "Bioprom: Industry and Technology for People," which will take place in Gelendzhik from October 6 to 7. This key event for the medical industry will unite leading companies in the biotechnology, medicine, and pharmaceuticals markets. The forum is held with the support of the Ministry of Industry and Trade of the Russian Federation and the Ministry of Health of the Russian Federation.
News: Press service of Rostec State Corporation